Company
Narval
We use Artificial Intelligence to design synthetic Antibody Mimetic Proteins to replace conventional antibodies in novel first-in-class therapeutics.
Mexico, North America TechCrunch Disrupt 2023
Details
Founded Date
2023
Industries
AI/Machine Learning
Biotech
HealthTech, Healthcare
Operating Status
Open
Currently Raising
Website
Founders
Jose Luis Nuno Founder